Search Results - Ampudia, FJ

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    PDB34 - Long-Term Cost-Effectiveness of Ideglira Versus Basal-Bolus Insulin As Intensification Therapies For People With Type 2 Diabetes Inadequately Controlled on Basal Insulin In Spain: Projections Based On The Dual VII Trial

    PDB34 - Long-Term Cost-Effectiveness of Ideglira Versus Basal-Bolus Insulin As Intensification Therapies For People With Type 2 Diabetes Inadequately Controlled on Basal Insulin In... by Ampudia, FJ, Mezquita, P, Ramirez de Arellano, A, Basse, A, Hunt, B

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Long-Term Cost-Effectiveness of Ideglira Versus Basal-Bolus Insulin As Intensification Therapies For People With Type 2 Diabetes Inadequately Controlled on Basal Insulin In Spain: Projections Based On The Dual VII Trial

    Long-Term Cost-Effectiveness of Ideglira Versus Basal-Bolus Insulin As Intensification Therapies For People With Type 2 Diabetes Inadequately Controlled on Basal Insulin In Spain:... by Ampudia, FJ, Mezquita, P, Ramirez de Arellano, A, Basse, A, Hunt, B

    Published in Value in health
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    POSB393 Profile of Patients with Type 1 or Type 2 Diabetes Treated with Insulin Lispro 100 Units/ML Junior Kwikpen in Routine Clinical Practice in Spain

    POSB393 Profile of Patients with Type 1 or Type 2 Diabetes Treated with Insulin Lispro 100 Units/ML Junior Kwikpen in Routine Clinical Practice in Spain by Rubio, M, Duque, N, Artime, E, Caveda, E, Spaepen, E, Díaz Cerezo, S, Ampudia-Blasco, FJ

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Following the results of the EMPA-REG OUTCOME trial with empagliflozin, is it possible to speak of a class effect?

    Following the results of the EMPA-REG OUTCOME trial with empagliflozin, is it possible to speak of a class effect? by Ampudia-Blasco, Francisco Javier, Romera, Irene, Ariño, Bernat, Gomis, Ramón

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    PDB8 THE IMPACT OF IMPROVED BETA-CELL FUNCTION ON MODELLING THE COST-EFFECTIVENESS OF ROSIGLITAZONE IN THE MANAGEMENT OF TYPE 2 DIABETES IN SPAIN

    PDB8 THE IMPACT OF IMPROVED BETA-CELL FUNCTION ON MODELLING THE COST-EFFECTIVENESS OF ROSIGLITAZONE IN THE MANAGEMENT OF TYPE 2 DIABETES IN SPAIN by Shearer, A, Bagust, A, Ampudia-Blasco, FJ, TaylorJ, MJ, Mendes da Costa, S

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: